Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer. [electronic resource]
- International journal of urology : official journal of the Japanese Urological Association 05 2016
- 360-9 p. digital
Publication Type: Journal Article; Review
1442-2042
10.1111/iju.13091 doi
Androgen Antagonists--therapeutic use Biomarkers, Tumor Disease Progression Humans Male Prostatic Neoplasms, Castration-Resistant--drug therapy Taxoids